Clinically and statistically significant improvement for efgartigimod in adults with ITP
In this MEDtalk dr. Catherine, Broome, associate, professor of Medicine at Med.Star Georgetown University Hospital in Washington, present the data of efficacy and safety for intravenous efgartigimod in adults with primary immune thrombocytopenia from the ADVANCE IV study, a multi-center double-blinded placebo controlled randomized clinical trial.